Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Preliminary Evidence on Long COVID in children

View ORCID ProfileDanilo Buonsenso, Daniel Munblit, Cristina De Rose, Dario Sinatti, Antonia Ricchiuto, Angelo Carfi, Piero Valentini
doi: https://doi.org/10.1101/2021.01.23.21250375
Danilo Buonsenso
1Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
2Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy
3Global Health Research Institute, Istituto di Igiene, Università Cattolica del Sacro Cuore, Roma, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Danilo Buonsenso
  • For correspondence: danilobuonsenso{at}gmail.com
Daniel Munblit
4Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child’s Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
5Inflammation, Repair and Development Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom
6Research and Clinical Center for Neuropsychiatry, Moscow, Russia
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristina De Rose
1Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dario Sinatti
1Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonia Ricchiuto
1Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angelo Carfi
7Geriatric Department, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Piero Valentini
1Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
3Global Health Research Institute, Istituto di Igiene, Università Cattolica del Sacro Cuore, Roma, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

There is increasing evidence that adult patients diagnosed with acute COVID-19 suffer from Long COVID initially described in Italy.

To date, data on Long COVID in children are lacking.

We assessed persistent symptoms in pediatric patients previously diagnosed with COVID-19. More than a half reported at least one persisting symptom even after 120 days since COVID-19, with 42.6% being impaired by these symptoms during daily activities. Symptoms like fatigue, muscle and joint pain, headache, insomnia, respiratory problems and palpitations were particularly frequent, as also described in adults.

The evidence that COVID-19 can have long-term impact children as well, including those with asymptomatic/paucisymptomatic COVID-19, highlight the need for pediatricians, mental health experts and policy makers of implementing measures to reduce impact of the pandemic on child’s health.

Background

There is increasing evidence that adult patients diagnosed with acute COVID-19 suffer from Long COVID initially described in Italy (1). A recent large cohort of 1733 patients from Wuhan found persistent symptoms in 76% of patients 6 months after initial diagnosis (2). To date, data on Long COVID in children are lacking. We assessed persistent symptoms in pediatric patients previously diagnosed with COVID-19.

Methods

This cross-sectional study included all children ≤18 year-old diagnosed with microbiologically-confirmed COVID-19 in Fondazione Policlinico Univeersitario A. Gemelli IRCCS (Rome, Italy). Patients > 18 years-old or with severe disability were excluded. Caregivers were interviewed about their child’s health using a questionnaire (supplementary material) developed by the Long Covid ISARIC study group (3), for evaluation of persisting symptoms. Participants were interviewed by two pediatricians, either online or in the outpatient department, from September 1st to January 1st. Participants were categorized into groups according to symptoms status during the acute phase (symptomatic/asymptomatic), need for hospitalization and time from COVID-19 diagnosis to follow-up evaluation (<60, 60-120, > 120 days). Numerical variables were compared using t-test or ANOVA, and categorical variables with χ2 or Fisher’s exact test where appropriate. All analyses were performed using R version 4.0.3 (R Foundation). This study was approved by the Institutional Ethics Committee and all participants consented to participate.

Results

129 children diagnosed with COVID-19 between March and November, 2020 were enrolled (mean age of 11 ± 4.4 years, 62 (48.1%) female). Subsequently, three developed Multisystem Inflammatory Syndrome (2.3%) and two myocarditis (1.6%). Patients were assessed on average 162.5 ± 113.7 days after COVID-19 microbiological diagnosis. 41.8% completely recovered, 35.7% had 1 or 2 symptoms and 22.5% had 3 or more. 52.7% had at least one symptom 120 days or more after diagnosis (Table 1).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1.

Demographic and Clinical Characteristics of the Study Sample (N = 129). PICU: pediatric intensive care unite; MIS-C; multisystem inflammatory syndrome in children.

Table 2 provides details about persistence of symptoms according to severity and length of follow-up. Insomnia (18.6%), respiratory symptoms (including pain and chest tightness) (14.7%), nasal congestion (12.4%), fatigue (10.8%), muscle (10.1%) and joint pain (6.9%), and concentration difficulties (10.1), were the most frequently reported symptoms. Although they were more common in symptomatic or hospitalized children, they were also described in those individuals who were asymptomatic during acute phase. 29 out of the 68 (42.6%) children assessed ≥120 days from diagnosis were still distressed by these symptoms.

View this table:
  • View inline
  • View popup
Table 2.

Persisting symptoms in children with COVID-19, according to symptoms, need of hospitalization and distance from diagnosis of acute COVID-19. NA: not applicable. Others include: hair loss (n 2) and skin peeling (n 1)

Discussion

To our knowledge, this is the first study providing evidence of Long Covid in children. More than a half reported at least one persisting symptom even after 120 days since COVID-19, with 42.6% being impaired by these symptoms during daily activities. Symptoms like fatigue, muscle and joint pain, headache, insomnia, respiratory problems and palpitations were particularly frequent, as also described in adults (1, 2).

Limitations of the study include the single-center design with a relatively small sample size. All patients were interviewed once, however this study is designed to continue periodic assessments until 24 months after COVID-19 diagnosis and to include household members of different age groups, with or without COVID-19 as a control group.

Children have been mostly overlooked during this pandemic, since the clinical course of COVID-19 in this group is much milder than in adults (4). However, there is an increasing evidence that restrictive measures aimed at limiting the pandemic are having a significant impact on child’s mental health (5). Childhood is a delicate and fundamental period of life, critical for acquisition of social, behavioral and educational development. The evidence that COVID-19 can have long-term impact children as well, including those with asymptomatic/paucisymptomatic COVID-19, highlight the need for pediatricians, mental health experts and policy makers of implementing measures to reduce impact of the pandemic on child’s health.

Data Availability

all data are available

Footnotes

  • Funding: nothing to declare

  • Conflict of interests: nothing to declare

  • Data statement availability: dataset is available upon request to the corresponding author

References

  1. 1-.↵
    Carfí A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020 Aug 11;324(6):603– 605. doi:10.1001/jama.2020.12603. PMID: 32644129; PMCID: PMC7349096.
    OpenUrlCrossRefPubMed
  2. 2-.↵
    Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, Luo J, Huang Z, Tu S, Zhao Y, Chen L, Xu D, Li Y, Li C, Peng L, Li Y, Xie W, Cui D, Shang L, Fan G, Xu J, Wang G, Wang Y, Zhong J, Wang C, Wang J, Zhang D, Cao B. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 Jan 16;397(10270):220–232. doi:10.1016/S0140-6736(20)32656-8.
    OpenUrlCrossRef
  3. 3-.↵
    Munblit D, Buonsenso D, DunnGalvin A, Garralda E, Jones C, Nicholls DE, Swann O, Semple MG, Sigfrid L, Whittaker EA, Warner JO, and the Paediatric Long COVID Working Group. The risk of overlooking children during the COVID-19 pandemic: Paediatric Long-COVID may be a ticking time bomb. Lancet Child Adolescent Health 2021; accepted
  4. 4-.↵
    Parri N, Lenge M, Cantoni B, Arrighini A, Romanengo M, Urbino A, Da Dalt L, Verdoni L, Giacchero R, Lanari M, Musolino AM, Biban P, La Fauci G, Pilotto C, Buonsenso D, Chiossi M, Agostiniani R, Plebani A, Zampogna S, Barbieri MA, De Masi S, Agostoni C, Masi S; CONFIDENCE RESEARCH GROUP. COVID-19 in 17 Italian Pediatric Emergency Departments. Pediatrics. 2020 Dec;146(6):e20201235. doi:10.1542/peds.2020-1235. Epub 2020 Sep 23. PMID: 32968031.
    OpenUrlAbstract/FREE Full Text
  5. 5-.↵
    Buonsenso D, Roland D, De Rose C, Vásquez-Hoyos P, Ramly B, Chakakala-Chaziya JN, Munro A, González-Dambrauskas S. SCHOOLS CLOSURES DURING THE COVID-19 PANDEMIC: A Catastrophic Global Situation. Pediatr Infect Dis J. 2021 Jan 12. doi:10.1097/INF.0000000000003052. Epub ahead of print. PMID: 33464019.
    OpenUrlCrossRefPubMed
Back to top
PreviousNext
Posted January 26, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Preliminary Evidence on Long COVID in children
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Preliminary Evidence on Long COVID in children
Danilo Buonsenso, Daniel Munblit, Cristina De Rose, Dario Sinatti, Antonia Ricchiuto, Angelo Carfi, Piero Valentini
medRxiv 2021.01.23.21250375; doi: https://doi.org/10.1101/2021.01.23.21250375
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Preliminary Evidence on Long COVID in children
Danilo Buonsenso, Daniel Munblit, Cristina De Rose, Dario Sinatti, Antonia Ricchiuto, Angelo Carfi, Piero Valentini
medRxiv 2021.01.23.21250375; doi: https://doi.org/10.1101/2021.01.23.21250375

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pediatrics
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3296)
  • Dentistry and Oral Medicine (364)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13381)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5155)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3271)
  • Health Policy (1142)
  • Health Systems and Quality Improvement (1192)
  • Hematology (431)
  • HIV/AIDS (1018)
  • Infectious Diseases (except HIV/AIDS) (14632)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (523)
  • Neurology (4928)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (726)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4216)
  • Public and Global Health (7506)
  • Radiology and Imaging (1706)
  • Rehabilitation Medicine and Physical Therapy (1014)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)